Literature DB >> 17673449

Adiposity and cardiovascular disease: are we using the right definition of obesity?

Paul Poirier.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17673449     DOI： 10.1093/eurheartj/ehm321

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  19 in total

1.  A new predictive equation for evaluating women body fat percentage and obesity-related cardiovascular disease risk.

Authors:  A De Lorenzo; A Nardi; L Iacopino; E Domino; G Murdolo; C Gavrila; D Minella; G Scapagnini; L Di Renzo
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

2.  Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial.

Authors:  Mitul B Kadakia; Caroline S Fox; Benjamin M Scirica; Sabina A Murphy; Marc P Bonaca; David A Morrow
Journal:  Heart       Date:  2011-08-23       Impact factor: 5.994

3.  Body composition in coronary heart disease: how does body mass index correlate with body fatness?

Authors:  Alban De Schutter; Carl J Lavie; Jose Gonzalez; Richard V Milani
Journal:  Ochsner J       Date:  2011

4.  Body composition and coronary heart disease mortality--an obesity or a lean paradox?

Authors:  Carl J Lavie; Alban De Schutter; Dharmendrakumar Patel; Surya M Artham; Richard V Milani
Journal:  Mayo Clin Proc       Date:  2011-09       Impact factor: 7.616

5.  Surgery for Obesity and Weight-Related Diseases Changes the Inflammatory Profile in Women with Severe Obesity: a Randomized Controlled Clinical Trial.

Authors:  Alan Robson Trigueiro de Sousa; Wilson Rodrigues Freitas Junior; Eduardo Araujo Perez; Elias Jirjoss Ilias; Anderson Soares Silva; Vera Lucia Santos Alves; João Pedro Ribeiro Afonso; Miriã Cândida Oliveira; Adriano Luís Fonseca; Marcos Mota da Silva; Maria Eduarda Moreira Lino; Manoel Carneiro Oliveira Junior; Rodolfo Paula Vieira; Wilson José Sena Pedro; André Luis Lacerda Bachi; Giuseppe Insalaco; Carlos Alberto Malheiros; Luis Vicente Franco Oliveira
Journal:  Obes Surg       Date:  2021-09-23       Impact factor: 4.129

6.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality.

Authors:  Abel Romero-Corral; Virend K Somers; Justo Sierra-Johnson; Yoel Korenfeld; Simona Boarin; Josef Korinek; Michael D Jensen; Gianfranco Parati; Francisco Lopez-Jimenez
Journal:  Eur Heart J       Date:  2009-11-20       Impact factor: 29.983

Review 7.  Targeting abdominal obesity in cardiology: can we be effective?

Authors:  Paul Poirier
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

8.  Body mass loss is a surrogate marker of frailty in heart failure.

Authors:  Hai M Tang; Loren Moon; Jun Yoshioka
Journal:  Int J Cardiol       Date:  2018-10-15       Impact factor: 4.164

Review 9.  New obesity classification criteria as a tool for bariatric surgery indication.

Authors:  Antonino De Lorenzo; Laura Soldati; Francesca Sarlo; Menotti Calvani; Nicola Di Lorenzo; Laura Di Renzo
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

10.  A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.

Authors:  Olivier F Bertrand; Paul Poirier; Josep Rodés-Cabau; Stéphane Rinfret; Lawrence Title; Vladimir Dzavik; Madhu Natarajan; Juan Angel; Nuria Batalla; Natalie Alméras; Olivier Costerousse; Robert De Larochellière; Louis Roy; Jean-Pierre Després
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.